Clinical Trial Update: Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating non-antithrombotic therapy versus single antiplatelet therapy after left atrial appendage closure in nonvalvular atrial fibrillation, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonvalvular Atrial Fibrillation

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: OCEAN-SHD Study Group | Conditions: Nonvalvular Atrial Fibrillation, Aspirin | Phase 4 | Status: RECRUITING